Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rexall Sundown first quarter sales up 24%; Pennex division posts loss despite sales rise.

This article was originally published in The Tan Sheet

Executive Summary

REXALL SUNDOWN FIRST QUARTER SALES RISE 24% to $36.9 mil., boosted by sales increases in each of the company's major business segments. Sales to retailers rose 23.6% for the quarter ended Nov. 30, mail order sales gained 5.3% and direct sales grew 34.3%. Sales to retailers included net sales from Pennex Labs of $5 mil., representing an increase of 100% over the first quarter of fiscal 1994.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083671

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel